Plasma levels of chemerin, an adipocytokine produced from the adipose tissues and liver,
are associated with metabolic syndrome and coronary artery disease (CAD). Chemerin and …

Chemerin acting via its distinct G protein-coupled receptor CMKLR1 (ChemR23), is a novel
adipokine, circulating levels of which are raised in inflammatory states. Chemerin shows …

Objectives Chemerin is a recently discovered adipokine that regulates adipocyte
differentiation and modulates chemotaxis and activation of dendritic cells and macrophages …

Objective—Obesity and hypertension are comorbid in epidemic proportion, yet their
biological connection is largely a mystery. The peptide chemerin is a candidate for …

Adipocytes produce adipokines, including chemerin, a chemoattractant that mediates effects
through its ChemR23 receptor. Chemerin has been linked to endothelial dysfunction and …

Background Depending on their anatomical location, different fat depots have a different
capacity to produce bioactive peptides, called adipokines. Adipokines produced by …

Background Chemerin is a novel adipokine that is associated with inflammation and
adipogenesis. However, it remains unclear whether chemerin is involved in patients with …

Currently, coronary artery disease (CAD) is considered a major ailment in humans with
widespread prevalence. CAD also accounts for high mortality rates around the world that …

Background Chemerin is an adipokine that signals through the G protein‐coupled receptor
ChemR23 and is associated with inflammation, glucose homeostasis, lipid metabolism and …

Chemerin is a peptide chemoattractant for macrophages and an adipokine regulating
adipocyte differentiation and metabolism. Plasma chemerin is increased in chronic …